These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Arvinas focuses on protein degradation, with its lead candidate, ARV-471, in Phase 3 trials for breast cancer. Read why we ...

NCCN Guidelines for Cervical Cancer now include Puma's neratinib monotherapy for 2nd line or later use in patients with ...

“We’re excited to partner with TScan as they advance their innovative hematology and solid tumor programs,” said Lauren Cole, Managing Director with SVB Life Science and Healthcare Practice. “Silicon ...

VMPL Chennai Tamil Nadu [India] December 23 Kauvery Hospital Vadapalani a leading healthcare institution in Chennai has ...

The HALL was originally created to address the shortage of healthcare workers in New Mexico. It is currently supporting a ...

Managing inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may soon become more advanced and ...

Dubai, United Arab Emirates - Mayo clinic announces the results of an innovative treatment approach that may offer ...

U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer ...

The global AI in oncology market, valued at US$1.92 billion in 2023, is forecasted to grow at a robust CAGR of 29.4%, ...

By living the organizational value statement, “We are better together,” Intermountain Health’s 34 hospitals across six states ...

The global AI in oncology market, valued at US$1.92 billion in 2023, is forecasted to grow at a robust CAGR of 29.4%, ...